Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
Coronavirus disease 2019 is a major threat to public health globally. Though its pathogenesis has not been fully elucidated, angiotensin-converting enzyme 2 (ACE2) has been recently identified as a receptor for the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the cell....
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/206b816da909444199c0f4f7c34d5205 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:206b816da909444199c0f4f7c34d5205 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:206b816da909444199c0f4f7c34d52052021-12-02T16:02:19ZRole and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 20192095-882X10.1016/j.cdtm.2020.05.003https://doaj.org/article/206b816da909444199c0f4f7c34d52052020-06-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095882X20300426https://doaj.org/toc/2095-882XCoronavirus disease 2019 is a major threat to public health globally. Though its pathogenesis has not been fully elucidated, angiotensin-converting enzyme 2 (ACE2) has been recently identified as a receptor for the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the cell. Here, we aimed to clarify the potential role of ACE2 in SARS-CoV-2-induced acute lung injury and its underlying mechanism. As a receptor for coronavirus, ACE2 mediates the entry of SARS-CoV-2 into cells in a similar way as for severe acute respiratory syndrome coronavirus (SARS-CoV). The high binding affinity of SARS-CoV-2 to ACE2 correlates with its efficient spread among humans. On the other hand, ACE2 negatively regulates the renin-angiotensin-aldosterone system (RAAS) primarily by converting angiotensin II to angiotensin 1–7, which exerts a beneficial effect on coronavirus-induced acute lung injury. Human recombinant ACE2 has been considered as a potential therapy for SARS-CoV-2 by blocking virus entry and redressing the imbalance of RAAS in SARS-CoV-2 infection. The level of ACE2 expression can be upregulated by treatment with an ACE inhibitor (ACEI) or angiotensin Ⅱ type 1 receptor blocker (ARB). To date, no evidence shows that ACEIs or ARBs increase the susceptibility and mortality of patients infected with SARS-CoV-2, and hence, it is not advisable to discontinue such drugs in patients with cardiovascular disease.Meng-Yuan LiuBo ZhengYan ZhangJian-Ping LiKeAi Communications Co., Ltd.articleSevere acute respiratory syndrome coronavirus 2Angiotensin-converting enzyme 2Acute lung injuryMedicine (General)R5-920ENChronic Diseases and Translational Medicine, Vol 6, Iss 2, Pp 98-105 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Severe acute respiratory syndrome coronavirus 2 Angiotensin-converting enzyme 2 Acute lung injury Medicine (General) R5-920 |
spellingShingle |
Severe acute respiratory syndrome coronavirus 2 Angiotensin-converting enzyme 2 Acute lung injury Medicine (General) R5-920 Meng-Yuan Liu Bo Zheng Yan Zhang Jian-Ping Li Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019 |
description |
Coronavirus disease 2019 is a major threat to public health globally. Though its pathogenesis has not been fully elucidated, angiotensin-converting enzyme 2 (ACE2) has been recently identified as a receptor for the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the cell. Here, we aimed to clarify the potential role of ACE2 in SARS-CoV-2-induced acute lung injury and its underlying mechanism. As a receptor for coronavirus, ACE2 mediates the entry of SARS-CoV-2 into cells in a similar way as for severe acute respiratory syndrome coronavirus (SARS-CoV). The high binding affinity of SARS-CoV-2 to ACE2 correlates with its efficient spread among humans. On the other hand, ACE2 negatively regulates the renin-angiotensin-aldosterone system (RAAS) primarily by converting angiotensin II to angiotensin 1–7, which exerts a beneficial effect on coronavirus-induced acute lung injury. Human recombinant ACE2 has been considered as a potential therapy for SARS-CoV-2 by blocking virus entry and redressing the imbalance of RAAS in SARS-CoV-2 infection. The level of ACE2 expression can be upregulated by treatment with an ACE inhibitor (ACEI) or angiotensin Ⅱ type 1 receptor blocker (ARB). To date, no evidence shows that ACEIs or ARBs increase the susceptibility and mortality of patients infected with SARS-CoV-2, and hence, it is not advisable to discontinue such drugs in patients with cardiovascular disease. |
format |
article |
author |
Meng-Yuan Liu Bo Zheng Yan Zhang Jian-Ping Li |
author_facet |
Meng-Yuan Liu Bo Zheng Yan Zhang Jian-Ping Li |
author_sort |
Meng-Yuan Liu |
title |
Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019 |
title_short |
Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019 |
title_full |
Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019 |
title_fullStr |
Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019 |
title_full_unstemmed |
Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019 |
title_sort |
role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019 |
publisher |
KeAi Communications Co., Ltd. |
publishDate |
2020 |
url |
https://doaj.org/article/206b816da909444199c0f4f7c34d5205 |
work_keys_str_mv |
AT mengyuanliu roleandmechanismofangiotensinconvertingenzyme2inacutelunginjuryincoronavirusdisease2019 AT bozheng roleandmechanismofangiotensinconvertingenzyme2inacutelunginjuryincoronavirusdisease2019 AT yanzhang roleandmechanismofangiotensinconvertingenzyme2inacutelunginjuryincoronavirusdisease2019 AT jianpingli roleandmechanismofangiotensinconvertingenzyme2inacutelunginjuryincoronavirusdisease2019 |
_version_ |
1718385258590633984 |